LISA OVESEN: Open Payments
NPI 1932451580 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,121 in 48 payments from 24 companies in 2025. Trend: 2023 $464 · 2024 $1,558 · 2025 $1,121
Food & beverage: $1,121
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $137 |
| Janssen Biotech, Inc. | 6 | $122 |
| Novartis Pharmaceuticals Corporation | 6 | $118 |
| GENZYME CORPORATION | 3 | $108 |
| Pharmacosmos Therapeutics Inc. | 1 | $108 |
| PFIZER INC. | 3 | $56 |
| Adaptive Biotechnologies Corporation | 2 | $54 |
| SANOFI-AVENTIS U.S. LLC | 2 | $44 |
| Daiichi Sankyo Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $34 |
Products named: IMBRUVICA, SCEMBLIX, SARCLISA, MONOFERRIC, TECVAYLI, ELREXFIO, clonoSEQ, TALVEY.
Industry payments across OH — which companies pay providers there.
